Kala Bio Inc. has received a notice from the Nasdaq Stock Market indicating that the company is not in compliance with the minimum bid price requirement of $1.00 per share, as its stock traded below this threshold for 30 consecutive business days. The company has been given a 180-day period, until July 20, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days. If Kala Bio does not meet this requirement, it may be eligible for an additional 180-day extension if it meets other listing standards and provides written intent to resolve the deficiency, potentially through a reverse stock split. Failure to regain compliance could result in the company’s stock being delisted from Nasdaq.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kala Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-26-000502), on January 23, 2026, and is solely responsible for the information contained therein.